EUVIMEDEUVIMED entdecken
Crossref

Wearable Sweat Biosystem with Dual Diffusion-Limiting Interface for Dynamic Hyperlactatemia Management in Critical Care

Yunxiang Long, Xiaosen Pan iD, Yao Chen, Nanpei Li, Wentong Wang, Yuqi Wang iD, Wanyu Zhang, Taozhe Liu, Qiuting Peng, Kun Yang, Guorui Jin iD, Chang Liu und 6 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c12805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Yunxiang Long und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical ICU, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an710061, China. Hauptthemen laut MEDLINE: Sweat, Wearable Electronic Devices, Biosensing Techniques, Hyperlactatemia. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Xi?an Jiaotong University, China Postdoctoral Science Foundation, Innovation and Technology Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperlactatemia is a critical indicator of tissue hypoperfusion, metabolic dysfunction, and an adverse prognosis in critically ill patients. Yet conventional monitoring depends entirely on intermittent, invasive blood sampling, which cannot capture the dynamic metabolic fluctuations required to guide timely clinical interventions. Herein, we report a wearable sweat-sensing device built on a dual-diffusion-limiting architecture for the continuous and accurate assessment of clinical hyperlactatemia. This system synergistically modulates lactate diffusion in sweat through a silane-network-encapsulated lactate oxidase layer coupled to a polyvinyl chloride layer. This design effectively delays enzyme saturation, extending the linear detection range for sweat lactate to 0–60 mM and thereby fulfilling the stringent requirements of critical care monitoring. The device also integrates real-time pH and temperature calibration to safeguard measurement accuracy in complex physiological environments. Moreover, linear mixed-effects analysis of 82 paired samples from 33 critically ill patients demonstrated a strong association between sweat and blood lactate levels, with a marginal R2 of 0.840. Sweat lactate effectively identified hyperlactatemia and predicted in-hospital mortality, yielding areas under the receiver operating characteristic curve values of 0.943 and 0.785, respectively. The integrated iontophoresis-microfluidics module further ensures high consistency with bedside arterial blood gas analysis, as validated by a marginal R2 of 0.811. Together, these results establish sweat biosensors as a promising platform for continuous metabolic monitoring, resuscitation assessment, and objective prognostic stratification in critical care settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SweatWearable Electronic DevicesBiosensing TechniquesHyperlactatemiaCritical CareLactic AcidHumansDiffusionMixed Function OxygenasesMonitoring, Physiologic

Stichwörter der Autor:innen

critical care managementdual diffusion-limiting interfaceelectrochemical sensinghyperlactatemiawearable sweat biosystem

Substanzen

Lactic AcidMixed Function Oxygenaseslactate 2-monooxygenase

Autor:innen und Institutionen

  • Department of Surgical ICU, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an710061, China.
  • Department of Hepatobiliary Surgery and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an710061, China.
  • The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an710049, China.
  • Bioinspired Engineering & Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an710049, China.
  • Key Laboratory of Surgical Critical Care and Life Support, Ministry of Education, Xi'an Jiaotong University, Xi'an710049, China.
  • Department of Biomedical Engineering, City University of Hong Kong, Hong Kong999077, China.

ORCID-Profile: Xiaosen Pan, Yuqi Wang, Guorui Jin, Jian Lv, Yunsheng Fang, Yu Song

Förderung

  • Xi?an Jiaotong University
  • China Postdoctoral Science Foundation
  • Innovation and Technology Fund
  • National Science and Technology Major Project
  • Chinese Youth Medical Innovation and Research Project
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Long, Y., Pan, X., Chen, Y., Li, N., Wang, W., Wang, Y., Zhang, W., Liu, T., Peng, Q., Yang, K., Jin, G., Liu, C., Lv, J., Xu, F., Qu, K., Fang, Y., Song, Y., & Lin, T. (2026). Wearable Sweat Biosystem with Dual Diffusion-Limiting Interface for Dynamic Hyperlactatemia Management in Critical Care. ACS Nano. https://doi.org/10.1021/acsnano.6c12805

Vancouver

Long Y, Pan X, Chen Y, Li N, Wang W, Wang Y, et al. Wearable Sweat Biosystem with Dual Diffusion-Limiting Interface for Dynamic Hyperlactatemia Management in Critical Care. ACS Nano. 2026. doi:10.1021/acsnano.6c12805

BibTeX
@article{Long2026,
  author = {Long, Yunxiang and Pan, Xiaosen and Chen, Yao and Li, Nanpei and Wang, Wentong and Wang, Yuqi and Zhang, Wanyu and Liu, Taozhe and Peng, Qiuting and Yang, Kun and Jin, Guorui and Liu, Chang and Lv, Jian and Xu, Feng and Qu, Kai and Fang, Yunsheng and Song, Yu and Lin, Ting},
  title = {Wearable Sweat Biosystem with Dual Diffusion-Limiting Interface for Dynamic Hyperlactatemia Management in Critical Care},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c12805}
}
Kostenlos starten →